Sandra A O'Toole Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2018

miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra A O'Toole Research Topics

Disease

35	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2009
31	Neoplasms (Cancer) 02/2019 - 09/2009
8	Carcinoma (Carcinomatosis) 01/2018 - 01/2009
8	Neoplasm Metastasis (Metastasis) 12/2016 - 10/2009
5	Carcinogenesis 01/2019 - 01/2011
5	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2017 - 10/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016 - 09/2013
4	Melanoma (Melanoma, Malignant) 10/2016 - 04/2014
3	Triple Negative Breast Neoplasms 01/2020 - 06/2013
3	Ductal Carcinoma 03/2017 - 06/2011
2	Hypoxia (Hypoxemia) 04/2011 - 02/2011
1	Lobular Carcinoma 02/2022
1	Breast Cyst 06/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2017
1	Hypertension (High Blood Pressure) 03/2017
1	Paralysis (Palsy) 01/2016
1	Lymphatic Metastasis 01/2016
1	Lung Neoplasms (Lung Cancer) 10/2013
1	Sarcoma (Soft Tissue Sarcoma) 10/2013
1	Adenocarcinoma 10/2013
1	Adenocarcinoma of Lung 04/2013
1	Pancreatic Cyst 01/2013

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2009
11	Proteins (Proteins, Gene)FDA Link 06/2020 - 11/2010
7	Phenobarbital (Luminal)FDA Link 10/2017 - 10/2009
6	Hormones (Hormone)IBA 11/2020 - 09/2009
6	Estrogen ReceptorsIBA 10/2017 - 10/2009
5	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 01/2011
5	ErbB Receptors (EGF Receptor)IBA 04/2015 - 10/2009
4	LigandsIBA 01/2021 - 06/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2017 - 10/2009
4	Messenger RNA (mRNA)IBA 12/2015 - 03/2010
3	Androgen Receptors (Androgen Receptor)IBA 06/2020 - 01/2016
3	ParaffinIBA 02/2019 - 04/2014
3	Tyrosine (L-Tyrosine)FDA Link 11/2013 - 11/2010
2	B7-H1 AntigenIBA 11/2020 - 07/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2017 - 02/2013
2	CytokinesIBA 03/2017 - 02/2013
2	src-Family KinasesIBA 12/2016 - 11/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2016 - 10/2013
2	Formaldehyde (Formol)FDA Link 10/2014 - 04/2014
2	Monoclonal AntibodiesIBA 08/2014 - 06/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2010 - 01/2010
1	MucinsIBA 02/2022
1	atezolizumabIBA 01/2021
1	Apolipoproteins D (Apo D)IBA 06/2020
1	AndrogensIBA 06/2020
1	Inhibitor of Differentiation Protein 1IBA 01/2020
1	CSK Tyrosine-Protein KinaseIBA 01/2019
1	Histone MethyltransferasesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Estrogen Receptor alphaIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Keratin-14 (Keratin 14)IBA 01/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2018
1	Cathepsin BIBA 12/2017
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 12/2017
1	CathepsinsIBA 12/2017
1	Cysteine (L-Cysteine)FDA Link 12/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2017
1	Cystatin AIBA 12/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2017
1	CarcinogensIBA 03/2017
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 03/2017
1	Complement System Proteins (Complement)IBA 03/2017
1	Angiotensin Receptor AntagonistsIBA 03/2017
1	bioplexIBA 03/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2017
1	Losartan (Cozaar)FDA LinkGeneric 03/2017
1	Dasatinib (BMS 354825)FDA Link 12/2016
1	Immune Checkpoint InhibitorsIBA 10/2016
1	Melanoma-Specific AntigensIBA 10/2016
1	Tyrosine Kinase InhibitorsIBA 04/2015
1	Tamoxifen FDA LinkGeneric 11/2013
1	Estrogens (Estrogen)FDA Link 11/2013
1	Discoidin Domain Receptor 2IBA 10/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2013
1	CateninsIBA 07/2013
1	Activating Transcription Factor 3IBA 07/2013
1	Progesterone FDA LinkGeneric 06/2013
1	HhAntag691IBA 03/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2013
1	Carbonic Anhydrase IXIBA 04/2011
1	UbiquitinIBA 02/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2011
1	Ligases (Synthetase)IBA 02/2011
1	human ERBB2 proteinIBA 02/2011
1	CohesinsIBA 01/2011
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011

Therapy/Procedure

16	Therapeutics 11/2020 - 01/2009
2	Radiotherapy 01/2018 - 12/2015
1	Immunotherapy 11/2020
1	Precision Medicine 04/2015
1	Drug Therapy (Chemotherapy) 01/2011